To: Board of Supervisors
From: Dr. Grant Colfax, Health Services Director
Report Title: Purchase Order with Priority Healthcare Distribution, Inc. dba Curascript Specialty Distribution
☒Recommendation of the County Administrator ☐ Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, a purchase order with Priority Healthcare Distribution, Inc. dba Curascript Specialty Distribution in an amount not to exceed $500,000 for the hormone implant Nexplanon to be used at the Contra Costa Regional Medical Center (CCRMC) and Health Clinics, and Detention Centers for the period from December 1, 2025 through November 30, 2026.
FISCAL IMPACT:
Approval of this action will result in expenditures of up to $500,000 and will be funded by Hospital Enterprise Fund I revenues.
BACKGROUND:
Priority Healthcare Distribution, Inc. is a pharmaceutical company that provides CCRMC, Health Centers, and the Martinez and West County Detention Centers with hormone implant Nexplanon to be used in the Obstetrics/Gynecology depts. Curascript is the sole provider for Nexplanon.
On November 5, 2024, the Board of Supervisors approved agenda item C.61 to execute purchase order #31436 with Priority Healthcare Distribution, Inc. dba Curascript Specialty Distribution in the amount of $500,000 for the period of December 1, 2024 through November 30, 2025. On October 14, 2025 the Purchasing Agent approved the continued use of Curascript Specialty Distribution.
CONSEQUENCE OF NEGATIVE ACTION:
If this action is not approved, Contra Costa Health will not be able to purchase Nexplanon for the patient population at CCRMC, Health Clinics, and Detention Centers.